Editas Medicine (EDIT) Property, Plant & Equipment (Net) Growth (3y) (2018 - 2025)
Powered by 
Analysis
Editas Medicine (EDIT) Property, Plant & Equipment (Net) Growth (3y) (2018 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 14.05% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 11.65% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 411.50% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -3.34% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 16.78% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.66% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 19.96% |
| 10 | Editas Medicine | 287.84 Mn | 141.19 Mn | - | -38.95% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -38.95% |
| Sep 30, 2025 | -34.84% |
| Jun 30, 2025 | -34.38% |
| Mar 31, 2025 | -22.02% |
| Dec 31, 2024 | -5.39% |
| Sep 30, 2024 | -0.45% |
| Jun 30, 2024 | -1.71% |
| Mar 31, 2024 | -2.02% |
| Dec 31, 2023 | -4.97% |
| Sep 30, 2023 | -6.34% |
| Jun 30, 2023 | -0.13% |
| Mar 31, 2023 | 2.64% |
| Dec 31, 2022 | 12.66% |
| Sep 30, 2022 | 15.43% |
| Jun 30, 2022 | 23.83% |
| Mar 31, 2022 | 29.26% |
| Dec 31, 2021 | -24.79% |
| Sep 30, 2021 | -26.71% |
| Jun 30, 2021 | -27.98% |
| Mar 31, 2021 | -29.10% |